These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 21531716)
1. Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells. Huber K; Doyon G; Plaks J; Fyne E; Mellors JW; Sluis-Cremer N J Biol Chem; 2011 Jun; 286(25):22211-8. PubMed ID: 21531716 [TBL] [Abstract][Full Text] [Related]
2. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. Lin S; Zhang Y; Ying H; Zhu H Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428 [TBL] [Abstract][Full Text] [Related]
3. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. Archin NM; Keedy KS; Espeseth A; Dang H; Hazuda DJ; Margolis DM AIDS; 2009 Sep; 23(14):1799-806. PubMed ID: 19590405 [TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events. Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921 [TBL] [Abstract][Full Text] [Related]
5. Reactivation of latent HIV by histone deacetylase inhibitors. Shirakawa K; Chavez L; Hakre S; Calvanese V; Verdin E Trends Microbiol; 2013 Jun; 21(6):277-85. PubMed ID: 23517573 [TBL] [Abstract][Full Text] [Related]
6. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. Jiang G; Espeseth A; Hazuda DJ; Margolis DM J Virol; 2007 Oct; 81(20):10914-23. PubMed ID: 17670825 [TBL] [Abstract][Full Text] [Related]
7. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923 [TBL] [Abstract][Full Text] [Related]
8. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression. Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886 [TBL] [Abstract][Full Text] [Related]
9. A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. Keedy KS; Archin NM; Gates AT; Espeseth A; Hazuda DJ; Margolis DM J Virol; 2009 May; 83(10):4749-56. PubMed ID: 19279091 [TBL] [Abstract][Full Text] [Related]
10. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors. Painter MM; Zaikos TD; Collins KL J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396 [TBL] [Abstract][Full Text] [Related]
11. Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB. Ying H; Zhang Y; Zhou X; Qu X; Wang P; Liu S; Lu D; Zhu H PLoS One; 2012; 7(11):e48832. PubMed ID: 23166597 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells. Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133 [TBL] [Abstract][Full Text] [Related]
14. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1. Choi BS; Lee HS; Oh YT; Hyun YL; Ro S; Kim SS; Hong KJ AIDS; 2010 Feb; 24(4):609-11. PubMed ID: 20154582 [TBL] [Abstract][Full Text] [Related]
15. Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells. Wightman F; Lu HK; Solomon AE; Saleh S; Harman AN; Cunningham AL; Gray L; Churchill M; Cameron PU; Dear AE; Lewin SR AIDS; 2013 Nov; 27(18):2853-62. PubMed ID: 24189584 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation. Shin HJ; DeCotiis J; Giron M; Palmeri D; Lukac DM J Virol; 2014 Jan; 88(2):1281-92. PubMed ID: 24227836 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation. Kuai Q; Lu X; Qiao Z; Wang R; Wang Y; Ye S; He M; Wang Y; Zhang T; Wu H; Ren S; Yu Q J Med Virol; 2018 Sep; 90(9):1478-1485. PubMed ID: 29704439 [TBL] [Abstract][Full Text] [Related]
18. Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation. Rasmussen TA; Schmeltz Søgaard O; Brinkmann C; Wightman F; Lewin SR; Melchjorsen J; Dinarello C; Østergaard L; Tolstrup M Hum Vaccin Immunother; 2013 May; 9(5):993-1001. PubMed ID: 23370291 [TBL] [Abstract][Full Text] [Related]
19. Discovery of a small molecule agonist of phosphatidylinositol 3-kinase p110α that reactivates latent HIV-1. Doyon G; Sobolewski MD; Huber K; McMahon D; Mellors JW; Sluis-Cremer N PLoS One; 2014; 9(1):e84964. PubMed ID: 24489654 [TBL] [Abstract][Full Text] [Related]
20. Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat. Maxwell JW; Falcinelli SD; Nefedov A; Dorfmeier C; Wu G; Dewey M; Webber AL; Archin NM; Margolis DM; Hazuda DJ; Barnard RJO; Howell BJ J Virol; 2020 Jun; 94(13):. PubMed ID: 32295913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]